Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CARDIS

Financiado

Cerrado

Early stage CARdio Vascular Disease Detection with Integrated Silicon Photonics

Early identification of individuals at risk for CVD allows early intervention to halt or reverse the pathological process. This is the driver of Medtronic and partners to develop a mobile, low-cost, non-invasive, point-of-care scr... ver más

31/01/2019

IMEC

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

INTERUNIVERSITAIR MICROELECTRONICA CENTRUM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 9 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-01-31

ICT-26-2014: Photonics KET Scope:Specific Challenge: Europe's photonics industry is facing fierce global market competition and...

I+D

Cerrada hace 10 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

9 Participantes

IMEC

721.41K€ | Lider

FUNDICO

150.00K€ | Participante

UNIVERSITEIT MAASTRICHT

176.92K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NISTAS Non invasive screening of the status of the vascular system 2M€ Cerrado

InSiDe Integrated silicon photonics for Cardiovascular Disease moni... 6M€ Cerrado

BES-2013-064913 PLATAFORMAS OPTICAS NO-INVASIVAS PARA TOMOGRAFIA EN 3D Y PAR... 84K€ Cerrado

PTQ-11-04851 Biosensor portátil para el diagnóstico de enfermedades cardi... 82K€ Cerrado

NIMBLE System "The NIMBLE System: A novel non-invasive and non-ionizing me... 3M€ Cerrado

Sniff-Nose A novel double point intravascular diagnostic probe with con... 71K€ Cerrado

Duración del proyecto: 49 meses Fecha Inicio: 2014-12-18
Fecha Fin: 2019-01-31

Líder del proyecto

INTERUNIVERSITAIR MICROELECTRONICA CENTRUM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Early identification of individuals at risk for CVD allows early intervention to halt or reverse the pathological process. This is the driver of Medtronic and partners to develop a mobile, low-cost, non-invasive, point-of-care screening device for CVD. Assessment of arterial stiffness by measurement of the aortic pulse wave velocity (aPWV) is included in the latest ESC/ESH guidelines for CVD risk prediction. Besides aPWV, early identification of arterial stenosis and cardiac contraction abnormalities can be used to improve CVD risk classification. However, no tools are available today to screen a large population at primary care on these parameters, and individuals that are considered to be at low or moderate risk are too often undiagnosed. The objective of CARDIS is to investigate and demonstrate the concept of a mobile, low-cost device based on a silicon photonics integrated laser Doppler vibrometer and validate the concept for the screening of arterial stiffness, detection of stenosis and heart failure. We will: •Investigate, design and fabricate the optical subsystems and components: silicon photonics chip with integrated Ge-detectors, micro-optics, micro-optical laser bench, optical package •Integrate the subsystems and build a multi-array laser interferometer system •Develop a process flow scalable to high volumes for all sub-systems and their integration steps •Investigate and develop the biomechanical model to translate optical signals related to skin-level vibrations into underlying CVD physiological events •Validate the system in a clinical setting Photonics integration is needed to enable a device that is mobile (small size, small weight, robust (no moving parts), low cost (high volume scalable process flow) and allows fast screening (laser array). The partners commit to protect IP whenever possible, disseminate results via open access and, if target specs are met, commercially exploit and transfer the technology to create social and economic impact.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores